Outcomes of hip arthroplasty in Parkinson's disease: a meta-analysis and systematic review

Association between frailty and clinical post-operative outcomes in patients following hip arthroplasty: a systematic review and meta-analysis

PURPOSE

This research determined the correlation between frailty and post-surgical complications, readmission, re-operation, and mortality in patients with hip arthroplasty through a meta-analysis.

METHODS

We screened PubMed, Web of Science, Embase, and the Cochrane Library for cohort research that explored the correlation between frailty and post-operative complications in patients who underwent hip arthroplasty from inception to August 31, 2022. The Newcastle-Ottawa scale was employed to assess the value of the involved studies. Statistical analyses of the meta-analysis were conducted utilizing Review Manager, version 5.3.

RESULTS

This research involved seven retrospective investigations involving 350,971 patients. The summed findings revealed that frailty is associated with total complications (relative risk [RR] = 3.07, 95% confidence interval [CI]:1.99-4.74), re-operation (RR = 1.98; 95% CI: 1.73-2.28), readmission (RR = 2.04; 95% CI: 1.87-2.22), and 30-day mortality (RR = 2.59, 95% CI: 1.16-5.79). Subgroup and sensitivity analyses revealed that the pooled findings of frailty predict that total complications, re-operation, readmission, and 30-day mortality were stable.

CONCLUSIONS

Pre-operative frailty was correlated with post-surgical complications in patients who underwent hip arthroplasty, including post-operative complications, re-operation, readmission, and 30-day mortality.

SYSTEMATIC REVIEW REGISTRATION

PROSPERO, identifier: CRD 42022350781.

Postsurgical morbidity and mortality favorably informs deep brain stimulation for new indications including schizophrenia and schizoaffective disorder

Background

Deep brain stimulation (DBS) shows promise for new indications like treatment-refractory schizophrenia in early clinical trials. In the first DBS clinical trial for treatment refractory schizophrenia, despite promising results in treating psychosis, one of the eight subjects experienced both a symptomatic hemorrhage and an infection requiring device removal. Now, ethical concerns about higher surgical risk in schizophrenia/schizoaffective disorder (SZ/SAD) are impacting clinical trial progress. However, insufficient cases preclude conclusions regarding DBS risk in SZ/SAD. Therefore, we directly compare adverse surgical outcomes for all surgical procedures between SZ/SAD and Parkinson's disease (PD) cases to infer relative surgical risk relevant to gauging DBS risks in subjects with SZ/SAD.

Design

In the primary analysis, we used browser-based statistical analysis software, TriNetX Live (trinetx.com TriNetX LLC, Cambridge, MA), for Measures of Association using the Z-test. Postsurgical morbidity and mortality after matching for ethnicity, over 39 risk factors, and 19 CPT 1003143 coded surgical procedures from over 35,000 electronic medical records, over 19 years, from 48 United States health care organizations (HCOs) through the TriNetX Research Network™. TriNetXis a global, federated, web-based health research network providing access and statistical analysis of aggregate counts of deidentified EMR data. Diagnoses were based on ICD-10 codes. In the final analysis, logistic regression was used to determine relative frequencies of outcomes among 21 diagnostic groups/cohorts being treated with or considered for DBS and 3 control cohorts.

Results

Postsurgical mortality was 1.01-4.11% lower in SZ/SAD compared to the matched PD cohort at 1 month and 1 year after any surgery, while morbidity was 1.91-2.73% higher and associated with postsurgical noncompliance with medical treatment. Hemorrhages and infections were not increased. Across the 21 cohorts compared, PD and SZ/SAD were among eight cohorts with fewer surgeries, nine cohorts with higher postsurgical morbidity, and fifteen cohorts within the control-group range for 1-month postsurgical mortality.

Conclusions

Given that the subjects with SZ or SAD, along with most other diagnostic groups examined, had lower postsurgical mortality than PD subjects, it is reasonable to apply existing ethical and clinical guidelines to identify appropriate surgical candidates for inclusion of these patient populations in DBS clinical trials.

The progress in quantitative evaluation of callus during distraction osteogenesis

The manual monitoring of callus with digital radiography (X-ray) is the primary bone healing evaluation, assessing the number of bridged callus formations. However, this method is subjective and nonquantitative. Recently, several quantitative monitoring methods, which could assess the recovery of the structure and biomechanical properties of the callus at different stages and the process of bone healing, have been extensively investigated. These methods could reflect the bone mineral content (BMC), bone mineral density (BMD), stiffness, callus and bone metabolism at the site of bone lengthening. In this review, we comprehensively summarized the latest techniques for evaluating bone healing during distraction osteogenesis (DO): 1) digital radiography; 2) dual-energy X-ray scanning; 3) ultrasound; 4) quantitative computed tomography; 5) biomechanical evaluation; and 6) biochemical markers. This evidence will provide novel and significant information for evaluating bone healing during DO in the future.